Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used?Mieke Carlier, Jan J. De Waele, Sofie Carrette et al.|Critical Care|2013Cited by 212
Therapeutic drug monitoring-based dose optimisation of piperacillin and meropenem: a randomised controlled trialJan J. De Waele, Alain Verstraete, Mieke Carlier et al.|Intensive Care Medicine|2013Cited by 190
Does consistent piperacillin dosing result in consistent therapeutic concentrations in critically ill patients? A longitudinal study over an entire antibiotic courseMieke Carlier, Jan J. De Waele, Sofie Carrette et al.|International Journal of Antimicrobial Agents|2014Cited by 53